Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer
Journal of Gynecologic Oncology · 2024
DOI: 10.3802/jgo.2024.35.e25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Yulian Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Cytoreduction Surgical Procedures, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Peritoneal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Libing Xiang and the Zhongshan Talent Foundation.
Abstract (Originalsprache)
OBJECTIVE: Metastases in the supragastric lesser sac (SGLS) are not only occult but are also barriers to complete resection of ovarian cancer. We describe a cohort of patients with SGLS disease undergoing debulking surgery. METHODS: We identified all patients who underwent evaluation and eventual resection of SGLS disease as part of cytoreductive surgery for stage IIIC-IVB high-grade epithelial ovarian cancer at our institution from January 2018 to August 2022. RESULTS: Thirty-three of 286 patients (11.5%) underwent resection of SGLS disease. Metastases in the SGLS were identified by preoperative imaging in 4 of 33 patients (12.1%). The median peritoneal cancer index score was 22 (range, 9-33). Through surgical exploration, metastases were frequently seen in the right diaphragm (100%), hepatorenal recess (97%), lesser omentum (81.8%), left diaphragm (78.8%), supracolic omentum (75.8%), anterior transverse mesocolon (72.7%), splenic hilum (63.6%), ligamentum teres hepatis (60.6%), and gallbladder fossa (51.5%). The lesser omentum was normal in 6 of 33 (18.2%) patients, despite metastases within the SGLS. A total of 54.5% of patients underwent complex surgery (surgical complexity scores; median, 8; range, 3-14). Complete resections were achieved in 19 (57.6%) patients. No complications were related to the resection of SGLS disease. The median length of progression-free survival was 24.8 months (95% confidence interval=16.6-32.9). CONCLUSION: Metastases to the SGLS are not uncommon in advanced ovarian cancer, particularly those with widely disseminated disease. Disease in this recess is rarely identified by preoperative imaging and deserves systematic surgical exploration to attain complete cytoreduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
- Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. xiang.libing@zs-hospital.sh.cn.
ORCID-Profile: Yulian Chen, Zhuozhen Sun, Songqi Cai, Yan Hu, Rong Jiang, Libing Xiang, Rongyu Zang
Förderung
- Libing Xiang and the Zhongshan Talent Foundation
Zitieren
APA
Chen, Y., Sun, Z., Cai, S., Hu, Y., Jiang, R., Xiang, L., & Zang, R. (2024). Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2024.35.e25
Vancouver
Chen Y, Sun Z, Cai S, Hu Y, Jiang R, Xiang L, et al. Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer. Journal of Gynecologic Oncology. 2024. doi:10.3802/jgo.2024.35.e25
BibTeX
@article{Chen2024,
author = {Chen, Yulian and Sun, Zhuozhen and Cai, Songqi and Hu, Yan and Jiang, Rong and Xiang, Libing and Zang, Rongyu},
title = {Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer},
journal = {Journal of Gynecologic Oncology},
year = {2024},
doi = {10.3802/jgo.2024.35.e25}
}
EUVIMED